Uloric

Despite multiple attempts; Takeda still manages to keep Uloric on the market

This page features: Cited Research Articles Uloric, the common brand name for the medication Febuxostat, manufactured by Takeda Pharmaceuticals, entered the US market in 2009.  Uloric is a pill that is advertised to manage gout, a condition that approximately 8.3 million people in the United States suffer from.  Gout is a type of arthritis that causes …

Despite multiple attempts; Takeda still manages to keep Uloric on the market Read More »

FDA Issues Safety Warning Due to Increased Death Rates From Febuxostat

This page features: Cited Research Articles In February of 2019, the FDA issued a new black box warning for the medication febuxostat, which users currently take for gout. The warning states that patients who take the drug are at an increased risk of death due to heart related complications. A recent report showed 15 recent deaths …

FDA Issues Safety Warning Due to Increased Death Rates From Febuxostat Read More »